Delivery Order SPE2DR25D7066-SPE2DR26F7ZUW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,707.89 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL in vial form, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,069.28 to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 ml vials on December 16, 2025, with completion scheduled for December 17, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,563.00 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for a critical corticosteroid medication used across military and federal healthcare systems. The contract will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,568.18 to Amerisourcebergen Drug Corp for the supply of Dexamethasone 120 mg/30 ml vials on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $6,930.96 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/mL vials on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.64 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on a firm fixed price basis. The contract, awarded December 8, 2025, with completion targeted for December 9, 2025, represents a routine pharmaceutical procurement supporting federal medical supply chain operations. This award carries no set-aside designation, indicating it was competitively awarded through open competition. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,778.44 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Dexamethasone 20 mg/5 mL vials (5 mL quantity). This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $1,117.74 delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 ml vials (5 ml quantity) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitively awarded transaction under the company's existing contract vehicles with DLA. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency has awarded a $1,475.48 delivery order to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials (5 ml quantity) under a firm fixed price contract type. The award was made on December 4, 2025, with an ultimate completion date of December 5, 2025, and is not designated as a set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,259.53 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dexamethasone 4 mg/mL vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZUWDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Dexamethasone 10 mg/ml vials, with a ceiling value of $12,540.76 and a firm fixed-price structure. The award was made on January 15, 2026, with an ultimate completion date of January 16, 2026, and represents a non-set-aside, competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor that supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to federal government agencies. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition. Dexamethasone is a corticosteroid commonly used in military and veteran healthcare settings for anti-inflammatory and immunosuppressant applications, making this product delivery consistent with the company's established role in supporting Defense Health Agency operations and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 1/14/26 |